Skip to main content

Meet the Analyst: Thomas Wakim & John Hester, Bell Potter Analyst

Bell Direct
December 17, 2024

Join us as we conclude our 2024 Meet the Analyst series with a bang. Our Market Analyst, Grady Wulff, sits down with Bell Potter’s analysts John Hester and Thomas Wakim for a comprehensive discussion on the healthcare sector.

From deciphering Neuren Pharmaceuticals (ASX:NEU) share price fluctuations to anticipating the news flow that will share 2025 guidance and identifying why Telix Pharmaceuticals (ASX:TLX) and Clarity Pharmaceuticals (ASX:CU6) are stocks to watch in the new year, John and Thomas cover it all in this final episode of the year.

In this video, John and Thomas discuss:

  • (1:48): the headwinds & tailwinds facing the healthcare sector
  • (7:10): why they are bullish on Neuren
  • (13:48): opportunities in healthcare stocks for 2025
  • (15:18): what’s on their clinical data radar for the upcoming year.

Market Insights 26 Feb

Julia Lee
February 26, 2016

Small Cap CEO Interview: Ahalife

Bell Direct
February 24, 2016

Bell Potter: Hybrid stocks

Bell Direct
January 28, 2016

Bell Potter outlook: resources

Bell Direct
January 26, 2016

Richard Hemming: small cap dividend stocks

Richard Hemming
January 22, 2016

Bell Potter Financials Outlook

Bell Direct
January 22, 2016

Travel Sector Outlook

Bell Direct
January 22, 2016